The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Irritable Bowel Syndrome (IBS) Market Research Report 2024
Synopsis
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
The global Irritable Bowel Syndrome (IBS) market was valued at US$ 4737.2 million in 2023 and is anticipated to reach US$ 12740 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome (IBS).
Report Scope
The Irritable Bowel Syndrome (IBS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irritable Bowel Syndrome (IBS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irritable Bowel Syndrome (IBS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Segment by Type
IBS-D Drug
IBS-C Drug
Others
Segment by Application
Women
Men
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome (IBS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
The global Irritable Bowel Syndrome (IBS) market was valued at US$ 4737.2 million in 2023 and is anticipated to reach US$ 12740 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome (IBS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome (IBS).
Report Scope
The Irritable Bowel Syndrome (IBS) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irritable Bowel Syndrome (IBS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irritable Bowel Syndrome (IBS) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Segment by Type
IBS-D Drug
IBS-C Drug
Others
Segment by Application
Women
Men
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome (IBS) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2019-2030)
2.2 Irritable Bowel Syndrome (IBS) Growth Trends by Region
2.2.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Size by Region (2019-2024)
2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Region (2025-2030)
2.3 Irritable Bowel Syndrome (IBS) Market Dynamics
2.3.1 Irritable Bowel Syndrome (IBS) Industry Trends
2.3.2 Irritable Bowel Syndrome (IBS) Market Drivers
2.3.3 Irritable Bowel Syndrome (IBS) Market Challenges
2.3.4 Irritable Bowel Syndrome (IBS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2019-2024)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2019-2024)
3.2 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
3.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2023
3.5 Irritable Bowel Syndrome (IBS) Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome (IBS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome (IBS) Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2019-2024)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2025-2030)
5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2019-2024)
5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
6.2 North America Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2019-2024)
8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
9.2 Latin America Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
9.4 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2019-2030)
10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2019-2024)
10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.1.5 Bausch Health Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
11.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.2.5 Allergan Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
11.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.3.5 Takeda Recent Development
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Detail
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Company Detail
11.5.2 Sebela Pharmaceuticals Inc Business Overview
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
11.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.5.5 Sebela Pharmaceuticals Inc Recent Development
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Company Detail
11.6.2 Astellas Pharmaceuticals Business Overview
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2019-2024)
11.6.5 Astellas Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
